Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning.
Lead poisoning remains one of the hazards of industrialized civilization. CaNa2 EDTA and dimercaprol, the usual therapeutic measures, have many side effects and can be given by parenteral route alone. The authors present a case of chronic lead poisoning caused by ingestion of contaminated flour ground in a primitive flour mill. The diagnosis was confirmed by the CaNa2 EDTA provocative test. Dimercaptosuccinic acid (DMSA) was given orally as a further provocation and resulted in an 11-fold increase in urinary lead excretion. A 5-day course of treatment with DMSA was instituted, during which symptoms abated, urinary lead excretion increased and the blood lead level decreased. No side effects were noticed. There has been no relapse over several months of follow-up. The authors conclude that the oral use of DMSA is effective, safe and convenient both as a provocative test in establishing the diagnosis of lead poisoning and as a therapeutic tool.
D000328:Adult; D001939:Bread; D004492:Edetic Acid; D005506:Food Contamination; D006801:Humans; D007854:Lead / Q000652:urine; D007855:Lead Poisoning / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D004113:Succimer / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D013438:Sulfhydryl Compounds; D007854:Lead; D004492:Edetic Acid; D004113:Succimer